James C. Coons

2.0k total citations
71 papers, 978 citations indexed

About

James C. Coons is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Internal Medicine. According to data from OpenAlex, James C. Coons has authored 71 papers receiving a total of 978 indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Cardiology and Cardiovascular Medicine, 20 papers in Pulmonary and Respiratory Medicine and 12 papers in Internal Medicine. Recurrent topics in James C. Coons's work include Atrial Fibrillation Management and Outcomes (19 papers), Heart Failure Treatment and Management (17 papers) and Pulmonary Hypertension Research and Treatments (16 papers). James C. Coons is often cited by papers focused on Atrial Fibrillation Management and Outcomes (19 papers), Heart Failure Treatment and Management (17 papers) and Pulmonary Hypertension Research and Treatments (16 papers). James C. Coons collaborates with scholars based in United States, Poland and Canada. James C. Coons's co-authors include Mark Schmidhofer, Jacob C. Jentzer, Sandra L. Kane‐Gill, Carlo J. Iasella, Amy L. Seybert, Philip E. Empey, Srinivas Murali, Glenn A. Hirsch, Pamela L. Smithburger and M. Patricia George and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and CHEST Journal.

In The Last Decade

James C. Coons

65 papers receiving 944 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James C. Coons United States 18 456 255 157 144 106 71 978
William F. McIntyre Canada 23 1.5k 3.3× 217 0.9× 148 0.9× 199 1.4× 75 0.7× 153 1.9k
Liang-Miin Tsai Taiwan 19 582 1.3× 176 0.7× 142 0.9× 85 0.6× 37 0.3× 53 958
S. Braun Germany 17 821 1.8× 430 1.7× 91 0.6× 184 1.3× 33 0.3× 46 1.3k
Luisa De Gennaro Italy 23 937 2.1× 291 1.1× 91 0.6× 93 0.6× 110 1.0× 92 1.3k
Ramiro Arellano Canada 20 363 0.8× 721 2.8× 225 1.4× 139 1.0× 145 1.4× 40 1.8k
Jeffrey A. Breall United States 21 1.0k 2.3× 663 2.6× 267 1.7× 106 0.7× 82 0.8× 55 1.5k
Özgür Akgül Türkiye 22 350 0.8× 516 2.0× 286 1.8× 60 0.4× 107 1.0× 73 1.5k
Shin Young Ahn South Korea 20 253 0.6× 212 0.8× 128 0.8× 21 0.1× 114 1.1× 87 1.2k
Hemant Phatak United States 22 1.0k 2.2× 187 0.7× 117 0.7× 390 2.7× 40 0.4× 87 1.7k

Countries citing papers authored by James C. Coons

Since Specialization
Citations

This map shows the geographic impact of James C. Coons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James C. Coons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James C. Coons more than expected).

Fields of papers citing papers by James C. Coons

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James C. Coons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James C. Coons. The network helps show where James C. Coons may publish in the future.

Co-authorship network of co-authors of James C. Coons

This figure shows the co-authorship network connecting the top 25 collaborators of James C. Coons. A scholar is included among the top collaborators of James C. Coons based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James C. Coons. James C. Coons is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ataya, Ali, James C. Coons, Meredith Broderick, et al.. (2025). Safety and pharmacokinetics of ralinepag, a novel oral prostacyclin receptor agonist. JHLT Open. 9. 100270–100270. 1 indexed citations
2.
Murugan, Mullai, Bo Yuan, Eric Venner, et al.. (2024). Empowering personalized pharmacogenomics with generative AI solutions. Journal of the American Medical Informatics Association. 31(6). 1356–1366. 22 indexed citations
3.
Coons, James C., Meredith Broderick, Dasom Lee, et al.. (2024). Practical management of oral treprostinil in patients with pulmonary arterial hypertension: Lessons from ADAPT, EXPEDITE, and expert consensus. Respiratory Medicine. 231. 107734–107734. 1 indexed citations
4.
Coons, James C., Michael A. Mathier, Suresh Mulukutla, et al.. (2024). Medication optimization clinic decreases hospitalizations and mortality for patients with heart failure with reduced ejection fraction. SHILAP Revista de lepidopterología. 47. 100470–100470.
5.
White, Evan M., et al.. (2024). Utilizing Theoretical Domains Framework to Determine Barriers to Evidence-Based Recommendations in Non-Valvular Atrial Fibrillation. Annals of Pharmacotherapy. 59(7). 628–635. 1 indexed citations
6.
Cavallari, Larisa H. & James C. Coons. (2024). Genetic Determinants of Response to P2Y12 Inhibitors and Clinical Implications. Interventional Cardiology Clinics. 13(4). 469–481.
7.
Coons, James C., et al.. (2023). Management Considerations for Pulmonary Arterial Hypertension Pharmacotherapy in the Intensive Care Unit. SHILAP Revista de lepidopterología. 11(5). 145–145. 1 indexed citations
8.
Barreto, Jason N., James C. Coons, Kellie J. Goodlet, et al.. (2023). Best practices for supporting and improving pharmacy resident research and quality improvement projects. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 7(1). 75–84. 2 indexed citations
9.
White, Evan M., et al.. (2023). DOAC Dosing Discordance Using Different Estimates of Kidney Function and Outcomes. The Journal of Clinical Pharmacology. 63(9). 1061–1066.
10.
11.
Coons, James C. & Philip E. Empey. (2023). Pharmacogenomics in the Management of Pulmonary Arterial Hypertension: Current Perspectives. Pharmacogenomics and Personalized Medicine. Volume 16. 729–737.
12.
Awdish, Rana, et al.. (2021). An expert panel Delphi consensus statement on the use of palliative care in the management of patients with pulmonary arterial hypertension. Pulmonary Circulation. 12(1). e12003–e12003. 5 indexed citations
13.
Reed, Brent N., Robert J. DiDomenico, J. Erin Allender, et al.. (2019). Survey of Anticoagulation Practices with the Impella Percutaneous Ventricular Assist Device at High-Volume Centers. Journal of Interventional Cardiology. 2019. 1–6. 23 indexed citations
14.
Hicks, J. Kevin, Christina L. Aquilante, Henry M. Dunnenberger, et al.. (2019). Precision pharmacotherapy: Integrating pharmacogenomics into clinical pharmacy practice. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 2(3). 303–313. 54 indexed citations
15.
Iasella, Carlo J., et al.. (2019). Effect of Selective Serotonin Reuptake Inhibitors on Cardiovascular Outcomes After Percutaneous Coronary Intervention: A Retrospective Cohort Study. Clinical Drug Investigation. 39(6). 543–551. 11 indexed citations
16.
Anderson, Kacey B., James C. Coons, Randall B. Smith, et al.. (2016). Advancing Pharmacogenomics Education in the Core PharmD Curriculum through Student Personal Genomic Testing. American Journal of Pharmaceutical Education. 80(1). 3–3. 68 indexed citations
17.
Coons, James C., et al.. (2015). Clinical effectiveness and safety outcomes associated with prothrombin complex concentrates. Journal of Thrombosis and Thrombolysis. 42(1). 6–10. 8 indexed citations
18.
Rivosecchi, Ryan, Mark J. Rice, Pamela L. Smithburger, et al.. (2014). An evidence based systematic review of remifentanil associated opioid-induced hyperalgesia. Expert Opinion on Drug Safety. 13(5). 587–603. 37 indexed citations
19.
Raina, Amresh, James C. Coons, Manreet Kanwar, et al.. (2013). Transitioning from Parenteral Treprostinil to Inhaled Treprostinil in Patients with Pulmonary Arterial Hypertension. Pulmonary Circulation. 3(1). 116–120. 8 indexed citations
20.
Kanwar, Manreet, Richa Agarwal, James C. Coons, et al.. (2012). Role of Phosphodiesterase-5 Inhibitors in Heart Failure: Emerging Data and Concepts. Current Heart Failure Reports. 10(1). 26–35. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by William F. McIntyre Breakdown of academic impact, for papers by Liang-Miin Tsai Breakdown of academic impact, for papers by S. Braun Breakdown of academic impact, for papers by Luisa De Gennaro Breakdown of academic impact, for papers by Ramiro Arellano Breakdown of academic impact, for papers by Jeffrey A. Breall Breakdown of academic impact, for papers by Özgür Akgül Breakdown of academic impact, for papers by Shin Young Ahn Breakdown of academic impact, for papers by Hemant Phatak
Rankless by CCL
2026